Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 2 1Phase 1 1

Status

Recruiting 12Completed 4Active not recruiting 4Withdrawn 1Terminated 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 68Gastrointestinal 38Genitourinary 33Breast 32Gynecologic 22Head & Neck 15Dermatologic 15Other solid neoplasm 13Tumor-Agnostic 12Lymphoid 9Other hematologic neoplasm 5Sarcoma 4CNS 4Plasma cell 2NET 1Endocrine 1

Conditions

Sarcoma 3Neoplasms 1Melanoma 1Head and Neck Neoplasms 1Gliosarcoma 1Glioblastoma 1

Interventions

Radiotherapy 144Doxorubicin 112Temozolomide 110Cyclophosphamide 110Filgrastim 79Ifosfamide 70Imatinib Mesylate 69Etoposide 69Bevacizumab 55Vincristine 51Gemcitabine 50Peripheral Blood Stem Cell Transplantation 47Irinotecan 43Methotrexate 39Cisplatin 36Carboplatin 36Radiation 35fludarabine phosphate 34Busulfan 34pazopanib 32Sirolimus 30Melphalan 30Trabectedin 29Docetaxel 27Chemotherapy, Adjuvant 27Cyclosporine 25Carmustine 25sargramostim 24Surgical Procedures, Operative 23Sunitinib 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × atezolizumab × Sarcoma × Clear all
NCT04216953 2026-04-23

COTESARC

Centre Leon Berard

Phase 1/2 Completed
229 enrolled
Sarcoma

Sarcoma

NCT03174197 2025-09-24

Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

M.D. Anderson Cancer Center

Phase 1/2 Completed
60 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

NCT03056599 2021-09-24

Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma

Presage Biosciences

Phase 1 Completed
23 enrolled
Sarcoma

Sarcoma

NCT02423863 2020-12-17

Poly-ICLC

Oncovir, Inc.

Phase 2 Completed
26 enrolled
DermatologicHead & NeckSarcoma

Head and Neck Neoplasms, Melanoma, Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡